What the dashboard does not show -- what it cannot show, because it was not designed for this purpose -- is whether those three findings share a common cause. Are three separate studies exhibiting the same type of delegation deficiency because the site's onboarding process has a systemic gap? Or are these three independent findings that happen to fall in the same domain?

That question matters enormously, and not in an abstract way. If the cause is systemic, fixing each study individually is a game of whack-a-mole. The RC resolves the delegation issue in Study 004, and six weeks later it reappears in Study 022 because the underlying onboarding process was never corrected. If the cause is coincidental -- Study 004 had a staff departure, Study 011 had a protocol amendment adding new procedures, Study 017 had an administrative oversight -- then the individual fixes are appropriate and no systemic action is needed.

Cross-study trend analysis is the discipline of answering that question. It is, in my view, the single most valuable analytical capability a regulatory coordinator can develop at the portfolio level, because it surfaces the problems that individual study reviews -- no matter how thorough -- structurally cannot detect.

What the dashboard does not show -- what it cannot show, because it was not designed for this purpose -- is whether those three findings share a common cause. Are three separate studies exhibiting the same type of delegation deficiency because the site's onboarding process has a systemic gap? Or are these three independent findings that happen to fall in the same domain?

That question matters enormously, and not in an abstract way. If the cause is systemic, fixing each study individually is a game of whack-a-mole. The RC resolves the delegation issue in Study 004, and six weeks later it reappears in Study 022 because the underlying onboarding process was never corrected. If the cause is coincidental -- Study 004 had a staff departure, Study 011 had a protocol amendment adding new procedures, Study 017 had an administrative oversight -- then the individual fixes are appropriate and no systemic action is needed.

Cross-study trend analysis is the discipline of answering that question. It is, in my view, the single most valuable analytical capability a regulatory coordinator can develop at the portfolio level, because it surfaces the problems that individual study reviews -- no matter how thorough -- structurally cannot detect.